EUVIMEDEUVIMED entdecken
Crossref

BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis

Qing Liu iD, Xinzhe Zhang, Lijing Wang, Haodong Chen, Gaojie Wang, Ye Sun, Baodong He, Jiao Gao, Wenying Qiu, Chao Ma, Miao Sun, Liying Cui und 1 weitere

Brain · 2026

DOI: 10.1093/brain/awag070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Qing Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), 100…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Agammaglobulinaemia Tyrosine Kinase, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program, CAMS Innovation Fund for Medical Sciences, PUMCH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with limited therapeutic interventions. Neuroinflammation represents a central pathogenic mechanism in ALS, yet the upstream molecular regulators that integrate multiple inflammatory cascades remain poorly understood. Here, we investigated whether Bruton’s tyrosine kinase (BTK), which integrates DNA-sensing and Toll-like receptor signals upstream of the cGAS–STING–NF-κB cascade, serves as a key regulatory node in ALS pathogenesis. Public RNA sequencing datasets of motor neurons (MNs) and post-mortem tissues from ALS patients were utilized to identify BTK expression patterns. SOD1-mutant human induced pluripotent stem cells (hiPSC) were differentiated into MNs (hiPSC-MNs) and microglia (hiPSC-MGs). NF-κB dysregulation was profiled by scRNA sequencing (hiPSC-MGs) and bulk RNA sequencing (hiPSC-MNs). DNA damage (γH2AX), inflammatory signalling (western blot/ELISA) and phagocytosis (pH-rodo uptake) were quantified, and microglial-conditioned medium was tested for MN toxicity. Monocultures and MN–MG co-cultures received zanubrutinib (3 µM, 12 h). SOD1-G93A mice were administered zanubrutinib (30 mg/kg, daily) from 2.5 months; motor performance, survival, spinal histology and PI3K–AKT–mTOR activity were assessed after 2 months of treatment. ALS spinal cord and cortex tissues of patients, as well as SOD1-mutant hiPSC-MG and hiPSC-MNs, demonstrated elevated BTK phosphorylation with increased p-STING, p-TBK1 and nuclear NF-κB accumulation. ALS hiPSC-MG exhibited inflammatory activation, NLRP3 induction and impaired phagocytosis, while ALS hiPSC-MNs showed DNA damage and caspase-3-mediated apoptosis. Conditioned medium from inflammatory MG amplified neuronal STING–NF-κB activity and apoptosis, demonstrating non-cell-autonomous toxicity. The STING inhibitor H-151 reduced neuronal p-STING/p-TBK1/NF-κB and apoptosis, confirming pathway causality. Pharmacological BTK inhibition reduced DNA damage in ALS hiPSC-MNs by 61.4% (P < 0.05), restored phagocytosis in ALS hiPSC-MG to 87.2% of control levels (P < 0.01) and prevented neuronal apoptosis induced by microglial conditioned medium. In SOD1-G93A mice, BTK blockade extended median survival from 158 to 183 days (P < 0.01, log-rank test), improved motor function, and attenuated neuroinflammation while moderately rebalancing PI3K–AKT–mTOR signalling without impairing autophagy–lysosome dynamics. We identify BTK as a critical upstream regulator of the dysregulated cGAS–STING–NF-κB signalling axis characteristic of ALS pathogenesis. BTK orchestrates both cell-autonomous dysfunction in MNs and non-cell-autonomous toxicity through microglial activation, representing a convergent regulatory node that integrates multiple pathogenic pathways. These mechanistic insights provide a molecular framework for understanding ALS neuroinflammation and establish a rational basis for BTK-targeted therapeutic intervention in neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAgammaglobulinaemia Tyrosine KinaseNeuroinflammatory DiseasesAnimalsHumansMiceMotor NeuronsMice, TransgenicMicrogliaInduced Pluripotent Stem CellsNF-kappa B

Stichwörter der Autor:innen

BTK inhibitorSTING-NF-κB pathwayamyotrophic lateral sclerosisneuroinflammation

Substanzen

Agammaglobulinaemia Tyrosine KinaseBTK protein, humanNF-kappa B

Autor:innen und Institutionen

  • Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), 100050, Beijing, China.
  • State Key Laboratory of Complex, Severe, and Rare Diseases, PUMCH, 102602, Beijing, China.
  • McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, CAMS & PUMC, 100050, Beijing, China.
  • Institute of Basic Medical Sciences, Neuroscience Center, National Human Brain Bank for Development and Function, Department of Human Anatomy, Histology and Embryology, CAMS & PUMC, 100050, Beijing, China.

ORCID-Profile: Qing Liu

Förderung

  • National Key Research and Development Program
  • CAMS Innovation Fund for Medical Sciences
  • PUMCH
  • Independent Research Fund

Zitieren

APA

Liu, Q., Zhang, X., Wang, L., Chen, H., Wang, G., Sun, Y., He, B., Gao, J., Qiu, W., Ma, C., Sun, M., Cui, L., & Zhang, X. (2026). BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis. Brain. https://doi.org/10.1093/brain/awag070

Vancouver

Liu Q, Zhang X, Wang L, Chen H, Wang G, Sun Y, et al. BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis. Brain. 2026. doi:10.1093/brain/awag070

BibTeX
@article{Liu2026,
  author = {Liu, Qing and Zhang, Xinzhe and Wang, Lijing and Chen, Haodong and Wang, Gaojie and Sun, Ye and He, Baodong and Gao, Jiao and Qiu, Wenying and Ma, Chao and Sun, Miao and Cui, Liying and Zhang, Xue},
  title = {BTK inhibition suppresses neuroinflammation and neurodegeneration in amyotrophic lateral sclerosis},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag070}
}
Kostenlos starten →